Skip to main content

Table 4 Comparison of CMT between Ozurdex and triamcinolone at each follow up visit

From: Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety

  Ozu (n = 20) mean CMT-µm Versus Baseline; P value Tri (n = 20) mean CMT-µm Versus baseline; P value Ozu versus Tri P value
Baseline 555 552 0.5362
4 weeks 450 0.0050* 402 0.0050* 0.4254
8 weeks 350 0.0050* 330 0.0050* 0.4037
12 weeks 270 0.0049* 240 0.0050* 0.6201
24 weeks 232 0.0050* 230 0.0050* 0.4244
  1. *Statistically significant